InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Longitude Capital Partners III, LLC. Officer active across 3 companies, notably Talaris Therapeutics, Inc.. In total, 8 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €13m. History available since 25 January 2022. The latest transaction was filed on 27 April 2022 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
175,000 shares0Common StockSEC:0000899243-22-016052:0
1,355,000 shares@ US$3.69100.0% of flowCommon StockSEC:0000899243-22-015325:0
Ideal exit: 14 Jan 2023 (T+270)
175,000 shares@ US$27.0021.2% of flowCommon StockSEC:0000899243-22-004271:0
Ideal exit: 30 Oct 2022 (T+270)
175,000 shares@ US$27.0042.4% of flowCommon StockSEC:0000899243-22-004271
Ideal exit: 30 Oct 2022 (T+270)
487,451 shares@ US$13.2028.8% of flowCommon StockSEC:0000899243-22-003502:0
487,451 shares@ US$13.2057.6% of flowCommon StockSEC:0000899243-22-003502
2,985,775 sharesCommon StockSEC:0000899243-21-019166:0
2,985,775 sharesCommon StockSEC:0000899243-21-019166
8 of 8 declarations
About Longitude Capital Partners III, LLC
Longitude Capital Partners III, LLC is a director and insider, primarily involved with Talaris Therapeutics, Inc.
